Open Access Open Access  Restricted Access Subscription Access

“A Validated UV Spectroscopic method for Quantification of Lidocaine HCl and Diltiazem HCl”

Nirali Chaudhari, Sanika Saskshee, Shruti Patel, Jay Chandwani, Heta Kachhiya

Abstract


A Simple and routinely used UV- Spectroscopic technique has been developed for estimating Lidocaine hydrochloride and Diltiazem hydrochloride in bulk and combined dosage form. The simultaneous estimation using first- order derivative analysis was 0.1 M HCl solvent, with scanning at wavelengths of 223 nm and 250 nm for quantifying lidocaine HCl and Diltiazem HCl, respectively. The concentration range for both drugs were 10-50 µg/ml. Comprehensive validation encompassed linearity, Accuracy, Precision, Loss of Detection (LOD), Loss of Quantification (LOQ), Ruggedness and Robustness assessments. The LOD values were determined to be1.32µg/ml for Lidocaine HCl and 6.18µg/ml for diltiazem HCl, while the LOQ values were found to be 4µg/ml and 18.75µg/ml, respectively. Notably, the corelation coefficient for both Lidocaine HCl and Diltiazem HCl was calculated to be 0.997. The proposed methodology was effectively applied for quantitatively determining Lidocaine HCl and Diltiazem HCl in Pharmaceutical dosage form.


Full Text:

PDF

References


USP NF; The United States Pharmacopoeia Convention Inc. Assian Edi, Canada, pp 1087-1088.

British Pharmacopoeia; British Pharmacopoeia Commission, the Department of Health, Social Services and Public Safety, 5th Edn.Volume II, London, 2011, pp1302-1304.

Lidocaine HCl, “Drug profile”, accessed on 18 December 2023, Lidocaine: Uses, Interactions, Mechanism of Action | DrugBank Online

Indian Pharmacopoeia; Indian Pharmacopoeia Commission, Government of India Ministry of Health and Family Welfare, Controller of India, Delhi, 2018, pp 1842- 1843.

Diltiazem HCl, “Drug profile”, accessed on 18 December 2023, Diltiazem: Uses, Interactions, Mechanism of Action | DrugBank Online.

Han k, Shaker AA, Maan A, and Hussein HH, “Estimation of lidocaine-HCL in Pharmaceutical drugs by HPLC-UV system.” Am J Pharm Tech Res. 2017, 7(1),2249-3387.

Ljiljana Z, Agatonovic K, and Nemcov I., “Comparison of high performance and thin layer chromatographic methods for the assay of lidocaine.” J. Pharm. Biomed. Anal.1996, 14(8-10),1229-1232.

Hamdah MA, Matthew P, James. SG and Dion RB, “HPLC Assay method for the determination of lidocaine in Human Serum.” Pharmaceutics.2017,9(4),52.

Salas S, Talero B, Rabasco AM, Gonzalez RM, “Development and validation of a reverse phase liquid chromatographic method for the assay of lidocaine hydrochloride.” J. Pharm. Biomed. Anal .2008,47(3),501-507.

Margi G, and Rajashree M, “Development and validation of RP-HPLC Method for estimation of lidocaine in pharmaceutical dosage forms.” IJRR.2020,7(1).


Refbacks

  • There are currently no refbacks.